At Illumina, our goal is to apply innovative sequencing and array technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service.

Research Grants 79 show all


$14.1M
2012

$13.7M
2014

$13.9M
2015

$312.2K
2016

$231.2K
2017

Patents 3,003show all

  • 702
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 315
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 235
    B01J - Chemical or physical processes, e.g. catalysis or colloid chemistry
  • 219
    B01L - Chemical or physical laboratory apparatus for general use
  • 181
    C40B - Combinatorial chemistry
  • 140
    C12N - Microorganisms or enzymes
  • 101
    G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
  • 86
    G02B - Optical elements, systems, or apparatus
  • 73
    C07H - Sugars
  • 66
    B82Y - Specific uses or applications of nanostructures

Clinical Trials 13show all

3N/A1Phase 3

SEC Filings show all


214
8-K

59
10-Q

19
10-K

1
S-1

Contact Information

5200 Illumina Way
San Diego, CA 92122
United States

Overview

Total FundingEmployeesLast Funding DateStatus
5001-10000Ipo